Regional Health Concerns — Tropical & Endemic Disease Medicines

MedsMонк addresses the specific health challenges of South and Southeast Asia by stocking medicines for tropical and endemic conditions prevalent in the region. From antiviral therapies for Hepatitis B and C to treatments for tuberculosis, dengue, typhoid, and region-specific cancers — our regional health hub ensures patients across Asia have access to effective treatments at fair prices.

Regional Health Medicine Categories

Featured Regional Health Medicines

Osimert 80 mg Tablet

Molecule : OsimertinibManufacturer : Everest Pharma
Osimert 80 mg is a prescription oral tablet that contains osimertinib, a third-generation EGFR tyrosine kinase inhibitor (EGFR-TKI) developed specifically

Ninlib 200 mg Capsule

Molecule : NilotinibManufacturer : Hetero Healthcare
Ninlib 200 mg is a prescription anticancer medication used to treat Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML), a type of

Zyceva 150 mg Tablet

Molecule : ErlotinibManufacturer : Zydus Cadila
Zyceva Erlotinib 150 mg Tablets are manufactured by Zydus oncosciences in India and contain 150 mg of Cetuximab per tablet.

Geftib 250 mg Tablet

Molecule : GefitinibManufacturer : Glenmark
Geftib 250 mg Tablet is an antineoplastic medication classified as a tyrosine kinase inhibitor, with Gefitinib as its active ingredient.

Evermil 5 mg Tablet

Molecule : EverolimusManufacturer : Glenmark
Evermil 5mg Tablet contains everolimus, manufactured by Glenmark Pharmaceuticals. This medication serves a dual purpose in modern medicine – helping

Abevmy 400 mg Injection

Molecule : BevacizumabManufacturer : Mylan
Abevmy 400 mg Vial contains Bevacizumab, an anti-cancer monoclonal antibody used to treat various advanced solid tumors. It works by

Shop All Regional Health Medicines →

Country-Specific Import Guidelines

Import rules vary widely across the region. Our Import Guidelines section covers personal-use import regulations for India, Philippines, Indonesia, Thailand, Bangladesh, and more.